Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Hereditary Cancer 2 Disease 2 Colorectal Neoplasms 2 Sarcoma, Kaposi 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Neoplasms 1 Lung Neoplasms 1 Gynecologic Cancer 1 Genetic Diseases, Inborn 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colonic Neoplasms 1 Chronic Pain 1 Castleman Disease 1 Cancer Pain 1 Brain Neoplasms 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 59 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 13 Drug Therapy 12 Watchful Waiting 11 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Standard of Care 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 Immune Checkpoint Inhibitors 5 Antineoplastic Agents 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Patient Reported Outcome Measures 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Diagnostic Tests, Routine × Clear all

NCT03981809 2023-08-22

PainsCan

Universitaire Ziekenhuizen KU Leuven

Cancer Pain, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡